Cytek Biosciences develops flow cytometry and single-cell analysis technologies, including its patented Full Spectrum Profiling (FSP) technology and the Aurora and Northern Lights instrument suite.
Cytek Biosciences builds cell analysis solutions - flow cytometry and single-cell analysis technologies used across research and clinical study applications. Headquartered in Fremont, California, the company serves researchers worldwide, and its instruments are trusted by pharmaceutical companies, contract research organisations and academic research institutions. The work sits at the intersection of precision instrumentation and high-parametric data analysis software, a domain that rewards engineers of uncommon calibre.
At the core of the product line is Full Spectrum Profiling (FSP), patented technology that enables high-resolution, high-content and high-sensitivity cellular analysis. Around it sits an integrated suite of instruments - Aurora, Northern Lights and Aurora CS - designed to support flow cytometry workflows end to end. Together they constitute a tightly coupled hardware-and-software stack: optical instrumentation, signal processing and analysis tooling that must hold to the standards demanded by immunology, oncology, cell therapy, pharmaceuticals and clinical studies.
The company states a mission to enable the world to improve life through scientific innovation, pursued by providing powerful solutions for deep biological insights, streamlining workflows and accelerating scientific breakthroughs. For those drawn to problems where the engineering is consequential and the domain is exacting, few settings offer comparable depth.
